The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
May. 23, 2023
Filed:
Nov. 21, 2018
Applicant:
Inbiomotion S.l., Barcelona, ES;
Inventors:
Walter Martin Gregory, Ilkley, GB;
Juan Carlos Tercero, Madrid, ES;
Robert E. Coleman, Sheffield, GB;
Roger Gomis, Barcelona, ES;
Assignee:
INBIOMOTION S.L., Barcelona, ES;
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/675 (2006.01); A61P 35/04 (2006.01); A61K 31/663 (2006.01); A61K 45/06 (2006.01); C07K 16/28 (2006.01); C12Q 1/6886 (2018.01);
U.S. Cl.
CPC ...
A61K 31/675 (2013.01); A61K 31/663 (2013.01); A61K 45/06 (2013.01); A61P 35/04 (2018.01); C07K 16/2875 (2013.01); C12Q 1/6886 (2013.01); C12Q 2600/158 (2013.01);
Abstract
The present invention relates to the design of a customized therapy for a subject with breast cancer based on the c-MAF expression level and the menopausal status of the subject. In some embodiments, the customized therapy comprises an agent for avoiding, treating or preventing bone degradation. In some embodiments, the agent for avoiding, treating or preventing bone degradation is zoledronic acid. In other embodiments, the agent is clodronate or denosumab.